ZYME vs ANAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

ZYME

49.1
AI Score
VS
ZYME Wins

ANAB

44.3
AI Score

Investment Advisor Scores

ZYME

49score
Recommendation
HOLD

ANAB

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZYME ANAB Winner
Revenue 2.41M 25.56M ANAB
Net Income -44.16M -52.88M ZYME
Net Margin -1834.0% -206.9% ANAB
Operating Income -47.12M -34.64M ANAB
ROE -27.0% -414.9% ZYME
ROA -9.2% -16.0% ZYME
Total Assets 478.21M 329.68M ZYME
Cash 244.28M 248.47M ANAB
Current Ratio 10.82 7.58 ZYME
Free Cash Flow -45.93M -25.94M ANAB

Relative Price Performance (Last 90 Days)

ZYME 1M: -17.1% · 3M: -18.0% ANAB 1M: -15.4% · 3M: -19.6%

Current Technical Phase

ZYME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 35

RSI (14): 34.5 · Price: $21.81

ANAB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 44

RSI (14): 44.3 · Price: $53.66

Fundamentals Snapshot

Metric ZYME ANAB
Market Cap
Forward P/E 26.3 10.3
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% -0.1%
Gross Margin -0.7% 0.4%
Operating Margin -19.6% -1.4%
EPS -1.37 -1.02
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZYME is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.